Quantcast

Posts related to ‘Vivus’

76764023

Obesity and Weight Loss Drug Shipments Rising

Posted: April 19, 2013 at 9:10 am

VIVUS Inc. (NASDAQ: VVUS) is the king of weight loss drugs now that it is operating with the first pill to help assist weight loss in a decade. The company's ...
Read Full Story »
biotech

Merrill Lynch Offers Four Key Biotech Drug Updates

Posted: April 17, 2013 at 11:45 am

Biotech pipeline news and biotech drug news continues to hit. A report from Bank of America/Merrill Lynch is highlighting four small-cap to mid-cap biotech stocks with positive prescription trends so far ...
Read Full Story »
76764023

VIVUS FDA Approval of Qsymia Expands the Obesity Customer Base

Posted: April 16, 2013 at 3:21 pm

VIVUS, Inc. (NASDAQ: VVUS) has just secured Food and Drug Administration  approval of an amendment and modification to the Risk Evaluation and Mitigation Strategy for its weight-loss drug Qsymia. With ...
Read Full Story »
76764023

Positive Clinical Study Could Provide a Tailwind for Obesity Drugs (VVUS, ARNA, OREX)

Posted: February 1, 2013 at 9:04 am

According to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese or very overweight. Obesity-related medical conditions include heart attack, ...
Read Full Story »
biotech

Nine Big Expected Biotech Winners for 2013 (ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Posted: December 20, 2012 at 6:21 am

24/7 Wall St. is looking for the next great biotech stocks for 2013 after great gains have been seen in 2012. If you look at the consensus price targets from ...
Read Full Story »
76764023

Is There Finally a Winner in the Crowded Obesity Drug Market?

Posted: December 18, 2012 at 10:43 am

According to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese. Obesity-related medical conditions include heart attack, stroke, type-2 diabetes ...
Read Full Story »

Today’s Market Winners and Losers

Posted: September 21, 2012 at 10:46 am

The stock market is up Friday, with the Dow Jones Industrial Average up 0.33%, the Nasdaq up 0.59% and the S&P 500 up 0.43%. Today's winners include a pharmaceutical company ...
Read Full Story »

Weight Loss Drugs Eating Up FDA Approval

Posted: July 18, 2012 at 9:05 am

The history of weight loss drugs is sketchy at best. But VIVUS Inc. (NASDAQ: VVUS) is making up on all of its recent losses, after shares slid from almost $30 ...
Read Full Story »

Arena Obesity Pill Approved, Good For All Fat-Fighters (ARNA, VVUS, OREX, AGN)

Posted: June 27, 2012 at 1:22 pm

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) was halted today for news that the company's weight-loss drug called BELVIQ has been approved.  The news is good for all obesity drug makers today.  ...
Read Full Story »

VIVUS Scores FDA Backing For Qnexa Against Obesity (VVUS, OREX, ARNA)

Posted: February 22, 2012 at 4:36 pm

VIVUS, Inc. (NASDAQ: VVUS) is going to likely have a huge day on Thursday.  The FDA panel reviewing its Qnexa drug to treat obesity has voted overwhelmingly to offer FDA panel backing ...
Read Full Story »

BioWatch: VIVUS & Orexigen Looking More FDA-Favorable (VVUS, OREX, ARNA)

Posted: April 4, 2011 at 9:38 am

VIVUS Inc. (NASDAQ: VVUS) was recently shown as one of our five biotechs with 50% upside and news this morning is showing why VIVUS may be one of the only ...
Read Full Story »